Clinical Trial Update: A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma [Phase 2]

View source ↗

Summary

Phase II study update for 609A in advanced undifferentiated pleomorphic sarcoma is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma Soft Tissue
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• 609A

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: UNKNOWN